News Releases
The latest company news, press releases, and resources about Servier and everything our company has to offer.
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
01.18.2022Servier Group Reports Financial Year 2020/2021 Annual Results, R&D Strategy and Pipeline
12.11.2021Phase 3 Data Demonstrate TIBSOVO® (ivosidenib tablets) in Combination with Azacitidine Significantly Improves Event-Free Survival and Overall Survival in Patients with Previously Untreated IDH1-mutated Acute Myeloid Leukemia-
11.04.2021New Data at ASH 2021 Reinforces the Strength of Servier's Hematology Portfolio
-
08.25.2021Servier Announces FDA Approval of TIBSOVO® (ivosidenib tablets) in IDH1-Mutated Cholangiocarcinoma
-
08.02.2021Servier Announces Positive Topline Data from the Global Phase 3 Study of TIBSOVO® (ivosidenib tablets) in Combination with Azacitidine in Patients with Previously Untreated IDH1-mutated Acute Myeloid Leukemia
Media Contacts
Servier Media Relations
us2mediarelations@servier.com